Our scientists discover and develop potential treatments for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, a disease of the nerve cells in the brain and spinal cord that control voluntary muscle movement. Led by drug development experts and people with ALS, we are 100% focused on finding effective treatments to slow and stop this disease.